by Greg Kuehn | Feb 26, 2018 | Press Releases
In a recent article by Suzanne Elvidge, published in BiopharmaDIVE, Metabiomics was highlighted as a clinical development leader that is exploring the links between microbiota and colon cancer. The article, titled “Hunting for the ‘good’ and...
by Greg Kuehn | Jun 19, 2017 | Press Releases, Research News
Manassas, VA, June 19, 2017 – Metabiomics is proud to announce the completion of one of the largest case-controlled studies on the colorectal polyp microbiome. Titled “Metabiomics Neoplasia Clinical Research Study”, also referred to as MB-01 by Metabiomics, the...
by Greg Kuehn | Dec 16, 2015 | Press Releases
PRESS RELEASE Cambridge, UK and Aurora, CO December 16, 2015 Metabiomics Corp. announced it has secured a distribution agreement with Origin Sciences pursuant to which it will develop, test, and commercialize the novel OriCol™ gastrointestinal sampling technology for...
by Greg Kuehn | Sep 10, 2015 | Press Releases
San Diego, CA September 10, 2015 Metabiomics is pleased to be attending the 3rd annual Global Engage Microbiome R&D and Business Collaboraton Forum. Greg Kuehn, President and COO will be giving a talk on Day 2 (sept 11) covering the...
by Greg Kuehn | Mar 17, 2014 | Research News
Chevy Chase, MD, March 17, 2014 Metabiomics is pleased to announce the launch of a new IRB approved microbiome clinical research study titled “Metabiomics Neoplasia Clinical Research Study”, also referred to as MB-01. The ~200 patient study will be conducted in...
